Valuation Roche Holding AG London S.E.

Stocks

Real-time Estimate Cboe Europe Other stock markets 12:05:17 09/07/2026 BST			5-day change	1st Jan Change
333.35 ^CHF	+2.92%		0.00%	+1.94%

06:41am	Roche's Tuberculosis Test Receives CE Mark	MT
07-08	ABB Robotics Partners with Roche Diagnostics	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	267,167	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	1.93%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	277,749	271,061	263,388
Change	-	-21.41%	-15.51%	3.13%	25.04%	-0.18%	-2.41%	-2.83%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	17.8x	16.7x	15.4x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	6.62x	5.59x	4.75x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1x	2.42x	1.87x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.26x	4.09x	3.91x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.43x	4.15x	3.85x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	11x	10x	9.17x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	12.3x	11.2x	10.2x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	17.9x	16.6x	14.9x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.6%	6.04%	6.71%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.01	10.25	10.52
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	2.99%	3.06%	3.14%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.77	20.06	21.72
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.4%	51.1%	48.5%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,643	65,243	68,345
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,314	27,050	28,713
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,558	24,182	25,721
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,228	16,276	17,435
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,582	3,894	-3,779
Reference price ²	379.10	290.50	244.50	255.50	328.20	334.90	334.90	334.90
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.46x	12.91x	26.29x	0.56%	1,084B
JOHNSON & JOHNSON	28.11x	6.45x	17.52x	2.03%	634B
ABBVIE INC.	30.45x	7.46x	15.28x	2.72%	447B
ASTRAZENECA PLC	23.78x	4.98x	13.89x	1.75%	295B
NOVARTIS AG	21.66x	5.57x	13.46x	2.83%	285B
NOVO NORDISK A/S	14.26x	5.31x	10.9x	3.51%	218B
AMGEN INC.	24.07x	6.37x	11.22x	2.74%	199B
GILEAD SCIENCES, INC.	-48.15x	5.84x	32.48x	2.39%	169B
PFIZER INC.	11.77x	3.02x	7.45x	7.28%	137B
Average	15.71x	6.43x	16.50x	2.87%	385.22B
Weighted average by Cap.	24.35x	8.16x	18.88x	2.06%